Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms

Journal of Human Genetics

Volumn 56, Issue 1, 2011, Pages 41-46

  Ishii, Takeo ^a   Wakabayashi, Ritsuko ^a   Kurosaki, Hiroko ^a   Gemma, Akihiko ^a   Kida, Kozui ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

depression; genetic variation; pulmonary disease, chronic obstructive; serotonin plasma membrane transport proteins; smoking

Indexed keywords

SEROTONIN TRANSPORTER;

AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; SMOKING;

AGED; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SMOKING;

NICOTIANA TABACUM;

EID: 79251603910     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.133     Document Type: Article

References (39)

1. Murray, C. J. & Lopez, A. D. Evidence-based health policy-lessons from the global burden of disease study. Science 274, 740-743 (1996).
2. Fletcher, C. & Peto, R. The natural history of chronic airflow obstruction. Br. Med. J. 1, 1645-1648 (1977).
3. Silverman, E. K., Spira, A. & Pare, P. D. Genetics and genomics of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6, 539-542 (2009).
4. Quaak, M., van Schayck, C. P., Knaapen, A. M. & van Schooten, F. J. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur. Respir. J. 33, 468-480 (2009).
5. Minematsu, N., Nakamura, H., Iwata, M., Tateno, H., Nakajima, T., Takahashi, S. et al. Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema. Thorax 58, 623-628 (2003).
6. Pillai, S. G., Ge, D., Zhu, G., Kong, X., Shianna, K. V., Need, A. C. et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS. Genet. 5, e1000421 (2009).
7. Barnes, P. J. & Celli, B. R. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33, 1165-1185 (2009).
8. Ishikawa, H., Ohtsuki, T., Ishiguro, H., Yamakawa-Kobayashi, K., Endo, K., Lin, Y. L. et al. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomarkers Prev. 8, 831-833 (1999). (Pubitemid 29445021)
9. Chu, S. L., Xiao, D., Wang., C. & Jing, H. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males. Chin. Med. J. (Engl) 122, 1365-1368 (2009).
10. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389 (2003).
11. Ng, T. P., Niti, M., Tan, W. C., Cao, Z., Ong, K. C. & Eng, P. Depressive symptoms and chronic obstructive pulmonary disease: Effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch. Intern. Med. 167, 60-67 (2007).
12. Xu, W., Collet, J. P., Shapiro, S., Lin, Y., Yang, T., Platt, R. W. et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am. J. Respir. Crit. Care Med. 178, 913-920 (2008).
13. Kendler, K. S., Neale, M. C., MacLean, C. J., Heath, A. C., Eaves, L. J. & Kessler, R. C. Smoking and major depression. A causal analysis. Arch. Gen. Psychiatry 50, 36-43 (1993).
14. Global strategy for diagnosis, management, and prevention of COPD, http://www.goldcopd.com/ (accessed 13 April 2009).
15. Vestbo, J. & Lange, P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 166, 329-332 (2002).
16. Standardization of spirometry, 1994 update. American Thoracic Society. Am. J. Respir. Crit. Care Med. 152, 1107-1136 (1995).
17. Japanese Respiratory Society. The predicted values of spirometry and arterial blood gas analysis in Japanese. J. Jap. Resp. Soc. 39, Appendix (2001) (in Japanese).
18. Motohashi, N., Kimura, K., Ishii, T., Wakabayashi, R., Kurosaki, H., Motegi, T. et al.Emphysema on imaging is associated with quality of life in elderly patients with chronic obstructive pulmonary disease. Geriatr. Gerontol. Int. 10, 17-24 (2010).
19. Nakano, Y., Muro, S., Sakai, H., Hirai, T., Chin, K., Tsukino, M. et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am. J. Respir. Crit. Care Med. 162, 1102-1108 (2000).
20. Nakano, Y., Muller, N. L., King, G. G., Niimi, A., Kalloger, S. E., Mishima, M. et al. Quantitative assessment of airway remodeling using high-resolution ct. Chest 122, 271S-275S (2002).
21. Okazawa, M., Muller, N., McNamara, A. E., Child, S., Verburgt, L. & Pare, P. D. Human airway narrowing measured using high resolution computed tomography. Am. J. Respir. Crit. Care Med. 154, 1557-1562 (1996).
22. Orlandi, I., Moroni, C., Camiciottoli, G., Bartolucci, M., Pistolesi, M., Villari, N. et al. Chronic obstructive pulmonary disease: thin-section ct measurement of airway wall thickness and lung attenuation. Radiology 234, 604-610 (2005).
23. Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta. Psychiatr. Scand. 67, 361-370 (1983).
24. Bjelland, I., Dahl, A. A., Haug, T. T. & Neckelmann, D. The validity of the hospital anxiety and depression scale. An updated literature review. J. Psychosom. Res. 52, 69-77 (2002).
25. Higashi, A., Yashiro, H., Kiyota, K., Inokuchi, H., Hatta, H., Fujita, K. et al. Validation of the hospital anxiety and depression scale in a gastro-intestinal clinic. Nippon Shokakibyo Gakkai Zasshi 93, 884-892 (1996). (Pubitemid 27016516)
26. Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).
27. Holland, P. M., Abramson, R. D., Watson, R. & Gelfand, D. H. Detection of specific polymerase chain reaction product by utilizing the 5¢-3¢ exonuclease activity of thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 88, 7276-7280 (1991).
28. Baron, R.M. & Kenny, D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 51, 1173-1182 (1986).
29. Kenny, D.A. Mediation. Available at: http://davidakenny.net/cm/mediate. htm (Accessed September 8, 2010).
30. Sobel, M.E. Asymptotic confidence intervals for indirect effects in structural equation models. in Sociological Methodology (ed, Leinhart S). Vol. 13, 290-312 (Jossey-Bass, San Francisco, 1982).
31. Preacher,, K. J. Calculation for the Sobel test. Available at: http://www.people.ku.edu/Bpreacher/sobel/sobel.htm (Accessed September 8, 2010).
32. Herr, N. R. Mediation with dichotomous outcomes Available at: http://nrherr.bol.ucla.edu/Mediation/logmed.html (Accessed September 8, 2010).
33. MacKinnon, D. P. & Dwyer, J. H. Estimating mediated effects in prevention studies. Evaluation Rev. 17, 144-158 (1993).
34. Wang, J., Spitz, M. R., Christopher, I., Amos, C.I., Wilkinson, A. V., Wu, X . et al. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer 116, 3458-3462 (2010).
35. Barnes, P. J. Histamine and serotonin. Pulm. Pharmacol. Ther. 14, 329-339 (2001).
36. Bayer, H., Muller, T., Myrtek, D., Sorichter, S., Ziegenhagen, M., Norgauer, J. et al. Serotoninergic receptors on human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 36, 85-93 (2007).
37. Risch, N., Herrell, R., Lehner, T., Liang, K. Y., Eaves, L., Hoh, J. et al. Interaction between the serotonin transporter gene (5-httlpr), stressful life events, and risk of depression: A meta-analysis. JAMA 301, 2462-2471 (2009).
38. Hill, K., Geist, R., Goldstein, R. S. & Lacasse, Y. Anxiety and depression in end-stage COPD. Eur. Respir. J. 31, 667-677 (2008).
39. Hughes, J. R., Stead, L. F. & Lancaster, T. Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 1, CD000031 (2007).